← back to search

Sławomir Jeka

University of Bydgoszcz ·
🔎 Find collaborators in Rheumatology · Immunology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Rheumatology · Immunology
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Biosimilars and Bioanalytical Methods, and Autoimmune and Inflammatory Disorders Research.
h-index
30
citations
4,627
works
158
NIH funding
primary concept
email

Recent publications

Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies
Annals of the Rheumatic Diseases 2023cited by 40position: middledoi
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial
The Lancet Rheumatology 2023cited by 19position: middledoi
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
New England Journal of Medicine 2021cited by 296position: middledoi
The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis
International Journal of Molecular Sciences 2021cited by 146position: lastdoi
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine 2020cited by 641position: middledoi
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
The Lancet 2017cited by 490position: middledoi
THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)
Annals of the Rheumatic Diseases 2013cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mitsumasa Kishimoto · Kyorin University1 papers (2021–2021) · 1 papers (2023–2023) · 1 papers (2023–2023)Caroline Gordon · Sandwell & West Birmingham Hospitals NHS Trust1 papers (2013–2013) · 1 papers (2023–2023) · 1 papers (2023–2023)Joseph F. Merola · Southwestern Medical Center1 papers (2021–2021)R. Besuyen · AIMM Therapeutics (Netherlands)1 papers (2023–2023)Aileen L. Pangan · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2023–2023)Oleksandr Golovchenko · Agaplesion Markus Hospital1 papers (2023–2023)Dirk Vanderschueren · KU Leuven1 papers (2023–2023) · 1 papers (2013–2013)Qingfeng Dong · Shandong University1 papers (2023–2023)Huaxiang Liu · Shandong University1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Rheumatology · Immunology →